Pharmafile Logo
Pharmafocus logo
Advanced Search

Champix

Showing 7 posts of 7 posts found.

Pfizer says EMA lifts warning on its smoking cessation drug Champix

May 24, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Champix, EMA, Pfizer, anti-smoking, drug trial

US pharma giant Pfizer (NYSE: PFE) said the European Medicines Agency has lifted a warning on its anti-smoking drug Champix …

News
Champix image

FDA gives new safety warning on Pfizer’s Champix

March 10, 2015
Manufacturing and Production, Sales and Marketing Champix, Cochrane, FDA, MHRA, Pfizer, varenicline

The FDA has warned that Pfizer’s stop smoking drug Champix is linked with seizures, aggressive behaviour and blackouts. In its …

News

Smoke and fire in J&J Code breach

August 15, 2012
Sales and Marketing Champix, J&J, JJ, Johnson and Johnson, PMCPA, Pfizer

Johnson & Johnson has been censured for breaking the ABPI Code of Practice in printed information about its smoking cessation …

News
Champix image

Champix better than patches for smoking cessation

August 7, 2012
Sales and Marketing Champix, FDA, Pfizer, Zyban, smoking

New research shows that Pfizer’s Champix is better than nicotine patch therapy at helping smokers kick the habit. A Pfizer …

News
Enbrel

Forecasting future launch success

September 8, 2011
Sales and Marketing Champix, Enbrel, forecast planning, forecasting

Pharmaceutical companies are moving into new and sometimes very different (often specialised) therapy areas, because of global market conditions and …

Feature
Pfizer

Study claims cardiovascular risk to Pfizer’s Champix

July 6, 2011
Research and Development, Sales and Marketing Champix, Chantix, Pfizer, smoking cessation

Pfizer has been drawn into a war of words over its smoking cessation drug Champix after a review of existing …

News

Boost for Pfizer’s Champix from NHS quit smoking report

August 22, 2008
Sales and Marketing Champix, smoking

Pfizer's smoking cessation drug Champix is the most effective pharmaceutical aid to quitting, according to new figures. A report on …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025